“Effectively Collect Real World Evidence for Early Access Programs”. We have asked Stuart a few questions to reflect on the topic …
Insights
Conference attendance: Meet Inceptua Early Access & Unlicensed Medicines 2024
“Effectively Collect Real World Evidence for Early Access Programs”. We have asked Stuart a few questions to reflect on the topic …
Conference attendance: Meet Inceptua Clinical Trial Supply & Services in 2024
News and Press Releases
Cycle Pharmaceuticals and Inceptua Group Partner for a Free Goods Programme
Vesey Street Capital Partners, LLC has agreed to join us as investor and majority shareholder
MoCD Type A is a rapidly progressive autosomal recessive inborn error of metabolism